DE60106572D1 - IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN - Google Patents

IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN

Info

Publication number
DE60106572D1
DE60106572D1 DE60106572T DE60106572T DE60106572D1 DE 60106572 D1 DE60106572 D1 DE 60106572D1 DE 60106572 T DE60106572 T DE 60106572T DE 60106572 T DE60106572 T DE 60106572T DE 60106572 D1 DE60106572 D1 DE 60106572D1
Authority
DE
Germany
Prior art keywords
adreneous
alpha2
receptors antagonists
imidazol compounds
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60106572T
Other languages
English (en)
Other versions
DE60106572T2 (de
Inventor
Paavo Huhtala
Arto Karjalainen
Antti Haapalinna
Jyrki Lehtimaeki
Arja Karjalainen
Raimo Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of DE60106572D1 publication Critical patent/DE60106572D1/de
Publication of DE60106572T2 publication Critical patent/DE60106572T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60106572T 2000-01-14 2001-01-12 IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN Expired - Lifetime DE60106572T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia
FI20000073 2000-01-14
PCT/FI2001/000030 WO2001051472A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives

Publications (2)

Publication Number Publication Date
DE60106572D1 true DE60106572D1 (de) 2004-11-25
DE60106572T2 DE60106572T2 (de) 2006-02-09

Family

ID=8557065

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60106572T Expired - Lifetime DE60106572T2 (de) 2000-01-14 2001-01-12 IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN

Country Status (30)

Country Link
EP (1) EP1261588B1 (de)
JP (1) JP2003519688A (de)
KR (1) KR20020084091A (de)
CN (1) CN1187336C (de)
AR (1) AR029432A1 (de)
AT (1) ATE280161T1 (de)
AU (1) AU769896B2 (de)
BR (1) BR0107644A (de)
CA (1) CA2397283A1 (de)
CZ (1) CZ20022358A3 (de)
DE (1) DE60106572T2 (de)
DK (1) DK1261588T3 (de)
EE (1) EE200200389A (de)
ES (1) ES2228884T3 (de)
FI (1) FI20000073A0 (de)
GC (1) GC0000218A (de)
HK (1) HK1049999B (de)
HU (1) HUP0301008A3 (de)
IL (1) IL150506A0 (de)
MX (1) MXPA02006872A (de)
NO (1) NO323117B1 (de)
NZ (1) NZ519919A (de)
PE (1) PE20011230A1 (de)
PL (1) PL207281B1 (de)
PT (1) PT1261588E (de)
RU (1) RU2265598C2 (de)
SI (1) SI1261588T1 (de)
SK (1) SK286320B6 (de)
WO (1) WO2001051472A1 (de)
ZA (1) ZA200205301B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
KR101176699B1 (ko) 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
CN101535298A (zh) * 2006-11-16 2009-09-16 弗·哈夫曼-拉罗切有限公司 取代的4-咪唑类化合物
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
RU2235092C2 (ru) * 1997-12-04 2004-08-27 Оллерган Инк. Замещенные производные имидазола, способ введения активного соединения и способ лечения на основе этих соединений
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

Also Published As

Publication number Publication date
CN1395567A (zh) 2003-02-05
SK286320B6 (en) 2008-07-07
PL356884A1 (en) 2004-07-12
GC0000218A (en) 2006-03-29
CN1187336C (zh) 2005-02-02
EP1261588A1 (de) 2002-12-04
IL150506A0 (en) 2003-02-12
PL207281B1 (pl) 2010-11-30
NO20023298L (no) 2002-09-06
SK9982002A3 (en) 2003-03-04
MXPA02006872A (es) 2003-01-28
WO2001051472A9 (en) 2003-01-23
AU2853201A (en) 2001-07-24
ATE280161T1 (de) 2004-11-15
DK1261588T3 (da) 2005-02-14
HUP0301008A3 (en) 2004-01-28
NO20023298D0 (no) 2002-07-08
AR029432A1 (es) 2003-06-25
CZ20022358A3 (cs) 2007-12-19
JP2003519688A (ja) 2003-06-24
KR20020084091A (ko) 2002-11-04
HK1049999A1 (en) 2003-06-06
EP1261588B1 (de) 2004-10-20
FI20000073A0 (fi) 2000-01-14
HK1049999B (zh) 2005-05-13
RU2002121777A (ru) 2004-01-10
DE60106572T2 (de) 2006-02-09
PE20011230A1 (es) 2001-12-08
ES2228884T3 (es) 2005-04-16
BR0107644A (pt) 2002-10-08
PT1261588E (pt) 2005-02-28
AU769896B2 (en) 2004-02-05
NO323117B1 (no) 2007-01-08
WO2001051472A1 (en) 2001-07-19
HUP0301008A2 (hu) 2003-10-28
NZ519919A (en) 2003-10-31
RU2265598C2 (ru) 2005-12-10
SI1261588T1 (en) 2005-02-28
EE200200389A (et) 2003-10-15
CA2397283A1 (en) 2001-07-19
ZA200205301B (en) 2003-10-02

Similar Documents

Publication Publication Date Title
DE60022386D1 (de) Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
ATE384053T1 (de) Triazolderivate als tachykininrezeptor- antagonisten
ATE328871T1 (de) 4-phenyl-pyridin-derivate verwendbar als neurokinin-1 rezeptor antagonisten
ATE525378T1 (de) Himbacinanaloga als thrombinrezeptorantagonisten
EE200200588A (et) Bensoamiidpiperidiinühendid kui substants P antagonistid
DE60012031D1 (de) Piperazin verbindungen als tachykinin-antagonisten
NO20032861D0 (no) Heteroarylurea nevropeptid YY5-reseptorantagonister
NO20025754D0 (no) IL-8 Reseptor-antagonister
ATE309240T1 (de) Chinazolin-derivate als alpha-1 adrenerge antagonisten
ATE245653T1 (de) Imidazolverbindungen als phosphodiesterase vii- hemmer
ATE299698T1 (de) Il-8 rezeptor antagonisten
ATE377008T1 (de) Imidazolderivate als glutamatrezeptorantagonisten
DE60316411D1 (de) Thiazolderivate als npy-rezeptorantagonisten
ATE492535T1 (de) 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
ATE353215T1 (de) Il-8 rezeptor-antagonisten
DE60106572D1 (de) IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN
ATE286018T1 (de) Biphenylderivate als neurokinin-1 antagonisten
ATE244716T1 (de) Neue n-triazolylmethyl-piperazinderivate als neurokininrezeptor-antagonisten
MA25739A1 (fr) Antagonistes recepteurs il-8
ATE232869T1 (de) Tricyclische delta3-piperidine als alpha2- antagonisten
DE60210058D1 (de) Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
ATE495168T1 (de) Heteroarylsubstituierte imidazolderivate als glutamatrezeptorantagonisten
DE60336672D1 (de) Harnstoffderivate als IL-8-Rezeptorantagonisten
NO20024367D0 (no) IL-8 reseptorantagonister

Legal Events

Date Code Title Description
8364 No opposition during term of opposition